Oxford Genetics is a synthetic biology company taking an engineering approach to DNA, virus and cell line design, optimization and development. The business has been developing solutions that improve all aspects of mammalian gene expression, thereby maximizing the productivity of protein, antibody and virus systems. Our research has involved the testing of a wide array of sequence types, including proprietary promoters and untranslated regions, and the extensive screening of exogenous proteins that influence cell biology and system output. This screening has been coupled with in house algorithms for the batch optimization of genes and high-throughput design for DNA assembly. These skill sets have allowed us build a track record of delivering DNA design and cell line development projects for the improved production of antibodies, vaccines and viruses.